¼¼°èÀÇ º¯½Ç±Ý ½ÃÀå º¸°í¼­(2025³â)
Fecal Incontinence Global Market Report 2025
»óǰÄÚµå : 1730857
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,938,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,692,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ º¯½Ç±Ý ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ ±â°£ÀÇ ÁÖ¿ä µ¿Çâ¿¡´Â ±â¼úÀÇ Áøº¸, ¸ÂÃãÇü ÀÇ·á ¾îÇÁ·ÎÄ¡ÀÇ Ã¤¿ë, »ýºÐÇØ¼ºÀ¸·Î ¿¡ÄÚ Ä£È­Àû Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Àü±â ÀÚ±Ø ÀåÄ¡³ª Èí¼ö¼º °­È­ Á¦Ç° µîÀÇ Çõ½Å, µðÁöÅÐ Çコ ±â¼úÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

À§ÀåÀå¾ÖÀÇ À¯º´·ü Áõ°¡´Â ´ëº¯½Ç±Ý ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº °¡°ø½ÄǰÀÇ ´Ù·® ¼·Ã볪 ½ÄÀ̼¶À¯ ¼·Ãë·®ÀÌ ÀûÀº ½Ä»ýȰÀÇ È¥¶õ°ú ¶óÀÌÇÁ ½ºÅ¸ÀÏÀÇ º¯È­¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 6¿ù, Crohn's and Colitis Canada´Â IBD ȯÀÚ¼ö°¡ 2023³âÀÇ 32¸¸ 2,600¸í(Àα¸ÀÇ 0.8%)¿¡¼­ 2035³â¿¡´Â 47¸¸¸í(Àα¸ÀÇ 1.1%)À¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ¶ÇÇÑ 2023³â¿¡´Â 1¸¸ 1,000¸íÀÇ ½Å±Ô »ç·Ê°¡ ¿¹»óµÇ¾î 2035³â¿¡´Â 1¸¸ 4,000¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

º¯½Ç±Ý ½ÃÀåÀÇ ±â¾÷Àº ȯÀÚÀÇ Æí¾ÈÇÔÀ» °³¼±Çϰí, Ä¡·á ¼º°ú¸¦ ³ôÀ̰í, ½ÃÀå¿¡¼­ÀÇ Á¸À縦 È®´ëÇϱâ À§ÇØ °ñ¹Ý °Ç°­ ½Ã½ºÅÛ°ú °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. °ñ¹Ý °Ç°­ ½Ã½ºÅÛÀ̶õ °ñ¹Ý³»ÀÇ Àå±â³ª ±¸Á¶ÀÇ Áø´Ü, °ü¸®, °Ç°­ÁõÁøÀ» ¸ñÀûÀ¸·Î ÇÑ ´Ù¾çÇÑ ÀÇ·á±â¼ú, ¼­ºñ½º, Ä¡·á¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¿ä½Ç±Ý, °ñ¹Ý ÅëÁõ, Àç»ý»ê °Ç°­ ¹®Á¦ µî °ñ¹Ý ¹Ù´ÚÀÇ »óŸ¦ ÇØ°áÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 6¿ù, ¹Ì±¹ ÀÇ·á±â±â ȸ»çÀÎ Axena Health Inc.´Â ¹Ì±¹ ½ÄǰÀǾ౹ÀÇ Àΰ¡¸¦ ¹ÞÀº °ñ¹Ý°Ç°­½Ã½ºÅÛ 'Leva'¸¦ ¹ß¸ÅÇß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¸ð¼Ç ¼¾¼­¿Í ½Ç½Ã°£ Çǵå¹éÀ» »ç¿ëÇÏ¿© °ñ¹ÝÀú±ÙÀ» °­È­ÇÏ´Â ºñħ½ÀÀûÀÌ°í ¾à¹°À» »ç¿ëÇÏÁö ¾Ê´Â ¹æ¹ýÀ» Á¦°øÇÏ¸ç »ç¿ëÀÚ¸¦ ¸ÅÀÏ 5ºÐ°£ ¿îµ¿À¸·Î ¾È³»ÇÕ´Ï´Ù. ¿ø°Ý ÀÇ·á¿ÍÀÇ ÅëÇÕÀ¸·Î ÀÌ ½Ã½ºÅÛÀº ƯÈ÷ º¯½Ç±ÝÀ» ´ë»óÀ¸·Î Çϸç ȯÀÚ¿¡°Ô À¯¿ëÇϰí È¿°úÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«

Á¦36Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Fecal incontinence is the involuntary loss of bowel control, resulting in the unintentional passing of stool or gas. It can range from occasional stool leakage while passing gas to a complete inability to control bowel movements. Causes can include damage to muscles or nerves, diarrhea, constipation, or underlying medical conditions such as inflammatory bowel disease or neurological disorders.

The primary product types for managing fecal incontinence include absorbent products, anal inserts, electrical stimulation devices, and other related items. Absorbent products help control fecal incontinence by preventing leaks and providing comfort. These products are used by various age groups, including pediatric, adult, and elderly populations, and are applied in hospitals, clinics, home care environments, and other settings. They are available through a variety of distribution channels, such as online stores, pharmacies, specialty stores, and more.

The fecal incontinence market research report is one of a series of new reports from The Business Research Company that provides fecal incontinence market statistics, including the fecal incontinence industry global market size, regional shares, competitors with the fecal incontinence market share, detailed fecal incontinence market segments, market trends, and opportunities, and any further data you may need to thrive in the fecal incontinence industry. This fecal incontinence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fecal incontinence market size has grown strongly in recent years. It will grow from $2.19 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth during the historic period can be attributed to factors such as the rising incidence of injuries or trauma, the increasing prevalence of gastrointestinal disorders, higher healthcare spending, an aging population, the adoption of anti-diarrheal medications, and the expanding availability of treatment and management products.

The fecal incontinence market size is expected to see strong growth in the next few years. It will grow to $3.05 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of chronic diarrhea, higher demand for minimally invasive procedures, favorable reimbursement policies, the growing popularity of sacral nerve stimulation techniques, and rising investments in research and development. Key trends during this period include technological advancements, the adoption of personalized medicine approaches, a rising demand for biodegradable and eco-friendly products, innovations such as electrical stimulation devices and enhanced absorbent products, and the integration of digital health technologies.

The growing prevalence of gastrointestinal disorders is expected to drive the growth of the fecal incontinence market. Gastrointestinal (GI) disorders affect the digestive system, including the esophagus, stomach, intestines, liver, pancreas, and gallbladder. The increase in these disorders is linked to poor dietary habits and lifestyle changes, such as a high intake of processed foods and low fiber consumption. Conditions such as inflammatory bowel disease (IBD), chronic diarrhea, and irritable bowel syndrome (IBS) can lead to fecal incontinence by disrupting bowel function in various ways. For example, in June 2023, Crohn's and Colitis Canada reported that the number of people living with IBD is projected to grow from 322,600 in 2023 (0.8% of the population) to 470,000 by 2035 (1.1% of the population). Additionally, 11,000 new cases were expected in 2023, with projections increasing to 14,000 new cases by 2035. This rise in gastrointestinal disorders is driving the growth of the fecal incontinence market.

Companies in the fecal incontinence market are developing innovative solutions such as pelvic health systems to improve patient comfort, enhance treatment outcomes, and expand their market presence. A pelvic health system refers to various medical technologies, services, and treatments aimed at diagnosing, managing, and improving the health of pelvic organs and structures. These systems are designed to address pelvic floor conditions, including incontinence, pelvic pain, and reproductive health issues. For example, in June 2023, Axena Health Inc., a US-based medical device company, launched the Leva pelvic health system, which received U.S. Food and Drug Administration clearance. This system offers a non-invasive, drug-free method to strengthen pelvic floor muscles using motion sensors and real-time feedback, guiding users through five-minute daily exercises. With telehealth integration, the system specifically targets fecal incontinence, providing an accessible and effective solution for patients.

In January 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Axonics Inc. for $3.7 billion. This acquisition aims to enhance Boston Scientific's urology portfolio by incorporating Axonics' innovative technologies for treating urinary and bowel dysfunction. Axonics specializes in neuromodulation solutions for conditions such as overactive bladder (OAB), fecal incontinence, and urinary retention.

Major players in the fecal incontinence market are 3M Company, Medtronic plc, Medline Industries LP, Essity AB, B. Braun Melsungen AG, Domtar Corporation, Coloplast Corp., HARTMANN Direct, ConvaTec Group plc, Ontex Group NV, Hollister Incorporated, Abena Group, Laborie Medical Technologies, Home Care Delivered, 180 Medical, Attends Healthcare Products Inc., Principle Business Enterprises Inc., Carewell, NorthShore Care Supply, InControl Medical, Tranquility Products, Aeroflow Urology, Reliance Medical Inc., TZMO SA, and Allegro Medical.

North America was the largest region in the fecal incontinence market in 2024. The regions covered in fecal incontinence report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the fecal incontinence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fecal incontinence market consists of revenues earned by entities by providing services such as medical treatments, pelvic floor rehabilitation, surgical interventions, consultation, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The fecal incontinence market also includes sales of bowel management systems, anti-diarrheal drugs, laxatives, stool softeners, artificial sphincters, and nerve stimulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fecal Incontinence Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fecal incontinence market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for fecal incontinence ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fecal incontinence market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Fecal Incontinence Market Characteristics

3. Fecal Incontinence Market Trends And Strategies

4. Fecal Incontinence Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Fecal Incontinence Growth Analysis And Strategic Analysis Framework

6. Fecal Incontinence Market Segmentation

7. Fecal Incontinence Market Regional And Country Analysis

8. Asia-Pacific Fecal Incontinence Market

9. China Fecal Incontinence Market

10. India Fecal Incontinence Market

11. Japan Fecal Incontinence Market

12. Australia Fecal Incontinence Market

13. Indonesia Fecal Incontinence Market

14. South Korea Fecal Incontinence Market

15. Western Europe Fecal Incontinence Market

16. UK Fecal Incontinence Market

17. Germany Fecal Incontinence Market

18. France Fecal Incontinence Market

19. Italy Fecal Incontinence Market

20. Spain Fecal Incontinence Market

21. Eastern Europe Fecal Incontinence Market

22. Russia Fecal Incontinence Market

23. North America Fecal Incontinence Market

24. USA Fecal Incontinence Market

25. Canada Fecal Incontinence Market

26. South America Fecal Incontinence Market

27. Brazil Fecal Incontinence Market

28. Middle East Fecal Incontinence Market

29. Africa Fecal Incontinence Market

30. Fecal Incontinence Market Competitive Landscape And Company Profiles

31. Fecal Incontinence Market Other Major And Innovative Companies

32. Global Fecal Incontinence Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fecal Incontinence Market

34. Recent Developments In The Fecal Incontinence Market

35. Fecal Incontinence Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â